| 000 | 01062 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517111438.0 | ||
| 264 | 0 | _c20171219 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1365-2036 | ||
| 024 | 7 |
_a10.1111/apt.13730 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGounder, P P | |
| 245 | 0 | 0 |
_aLetter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma - authors' reply. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _c09 2016 |
||
| 300 |
_a650-1 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aCarcinoma, Hepatocellular |
| 650 | 0 | 4 | _aDNA, Viral |
| 650 | 0 | 4 | _aHepatitis B Surface Antigens |
| 650 | 0 | 4 |
_aHepatitis B virus _xgenetics |
| 650 | 0 | 4 | _aHepatitis B, Chronic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLiver Neoplasms |
| 700 | 1 | _aBulkow, L R | |
| 700 | 1 | _aMcMahon, B J | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 44 _gno. 6 _gp. 650-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/apt.13730 _zAvailable from publisher's website |
| 999 |
_c26315916 _d26315916 |
||